Xu Li-Ning, Xu Ying-Ying, Gao De-Wei
Department of General Surgery, Clinical Division of South Building, Chinese PLA General Hospital, Beijing, 100853, China.
Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou, 450003, China.
J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):523-528. doi: 10.1007/s11596-016-1619-2. Epub 2016 Jul 28.
This study examined the impact of the operative and peri-operative factors on the long-term prognosis of patients with primary liver cancer undergoing hepatectomy. A total of 222 patients with primary liver cancer who underwent hepatectomy were followed up from January 1986 to December 2010 at Chinese PLA General Hospital. The post-operative complication rate was 14.0% for all cases, 13.7% for hepatocellular carcinoma (HCC), 10.0% for cholangiocarcinoma. The 1-, 3-, 5- and 10-year overall survival rates in patients with primary liver cancer after resection were 76.6%, 57.6%, 41.4%, and 21.0%. The survival rates were significantly higher in the HCC group than in the cholangiocarcinoma group (P=0.000), in the non-anatomical resection group than in the anatomical resection group (P=0.005), in the female group than in the male group (P=0.002), in patients receiving no blood transfusion than in those who were given intra-operative blood transfusion (P=0.000), in patients whose intra-operative blood loss was less than 400 mL than in those who intra-operatively lost more than 400 mL (P=0.000). No significant difference was found in the survival rate between the HBsAg-positive group and the HBsAg-negative group (P=0.532). Our study showed that anatomical resection, blood loss and blood transfusion were predictors of poor survival after hepatectomy for primary liver cancer patients, and concomitant hepatitis B virus infection bore no relation with the post-resection survival.
本研究探讨了手术及围手术期因素对接受肝切除术的原发性肝癌患者长期预后的影响。1986年1月至2010年12月,解放军总医院对222例行肝切除术的原发性肝癌患者进行了随访。所有病例的术后并发症发生率为14.0%,肝细胞癌(HCC)为13.7%,胆管癌为10.0%。原发性肝癌患者切除术后1年、3年、5年和10年的总生存率分别为76.6%、57.6%、41.4%和21.0%。HCC组的生存率显著高于胆管癌组(P = 0.000),非解剖性切除组高于解剖性切除组(P = 0.005),女性组高于男性组(P = 0.002),未输血患者高于术中输血患者(P = 0.000),术中失血少于400 mL的患者高于术中失血超过400 mL的患者(P = 0.000)。HBsAg阳性组和HBsAg阴性组的生存率无显著差异(P = 0.532)。我们的研究表明,解剖性切除、失血和输血是原发性肝癌患者肝切除术后生存不良的预测因素,而乙型肝炎病毒感染与切除术后生存无关。